| Phase 11 trial |
|
Phase 1
|
NCT03966365 Comparator |
May → Aug 2019 |
glaucoma |
Laboratorios Sophia S.A de C.V. |
Completed
|
No outcome recorded
|
| Phase 22 trials |
|
Phase 2
|
NCT06177678 Comparator |
Feb → Sep 2024 |
ocular hypertension, open-angle glaucoma |
Kukje Pharma |
Unknown
|
No outcome recorded
|
|
Phase 2
|
NCT01814514 Comparator |
Jan 2011 → Mar 2013 |
hypertensive disorder |
Zahra Rabbani Khah |
Unknown
|
No outcome recorded
|
| Phase 2/31 trial |
|
Phase 2/3
|
NCT03034772 Comparator |
Feb 2017 → Feb 2019 |
wet macular degeneration |
Wills Eye |
Completed
|
No outcome recorded
|
| Phase 33 trials |
|
Phase 3
|
NCT07617532 Comparator |
Jun 2026 → Mar 2028 expected |
ocular hypertension, open-angle glaucoma |
Ache Laboratorios Farmaceuticos S.A. |
Not yet recruiting
|
No outcome recorded
|
|
Phase 3
|
NCT05973318 Comparator |
Apr 2017 → Sep 2018 |
open-angle glaucoma |
Jadran Galenski laboratorij d.d. |
Completed
|
No outcome recorded
|
|
Phase 3
|
NCT00767481 Comparator |
Oct 2008 → Feb 2009 |
glaucoma, ocular hypertension |
Alcon Research |
Terminated
|
No outcome recorded
|
| Phase 44 trials |
|
Phase 4
|
NCT00761995 Comparator |
Feb 2009 → Jul 2010 |
ocular hypertension, open-angle glaucoma |
Alcon Research |
Completed
|
No outcome recorded
|
|
Phase 4
|
NCT00796198 Comparator |
Dec 2008 → Jun 2009 |
glaucoma |
University of Turin, Italy |
Unknown
|
No outcome recorded
|
|
Phase 4
|
NCT00379834 Comparator |
Sep 2006 → Apr 2008 |
glaucoma |
West Virginia University |
Completed
|
No outcome recorded
|
|
Phase 4
|
NCT00822055 Comparator |
May 2005 → Nov 2006 |
ocular hypertension, open-angle glaucoma |
Allergan |
Completed
|
No outcome recorded
|
| Phase not applicable2 trials |
| — |
NCT01257698 Comparator |
Feb 2010 → Jun 2013 |
macular holes, retinal detachment |
Mid Atlantic Retina |
Completed
|
No outcome recorded
|
| — |
NCT00804115 Comparator |
Aug 2000 → Sep 2007 |
exfoliation syndrome, ocular hypertension |
The New York Eye & Ear Infirmary |
Unknown
|
No outcome recorded
|